The herpes simplex virus protein VP22 exhibits the unusual the levels of transported protein may be below those property of intercellular transport whereby after being synrequired for live detection, or that GFP fluorescence was thesised in a subpopulation of cells, in which it is largely quenched. The use of antibody to GFP was more sensitive cytoplasmic, the protein is transported to adjacent cells than intrinsic GFP fluorescence and allowed ready detection where it accumulates mainly in the nucleus. Here we examof transport and nuclear accumulation of VP22-GFP. Interine the transport of a fusion protein consisting of VP22 linked cellular transport was also confirmed in coplating experito the green fluorescent protein (GFP). Intercellular transments. Consistent with previous results showing a requireport, nuclear accumulation and chromatin binding of VP22-ment for the C-terminus of VP22 in transport of the native GFP could be detected by intrinsic GFP fluorescence in protein, a fusion protein consisting of GFP linked to the Nfixed cells. However, while the cytoplasmic localisation of terminal 1-192 residues of VP22 failed to transport between VP22-GFP could be detected in live cells actively synthesiscells. The results support the proposal that VP22 has the ing the protein, we were unable to detect intercellular transability to transport cargo proteins between cells and that it port by intrinsic GFP fluorescence in livecells, indicating that has significant potential in the field of gene therapy.
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Keywords: HSV-1; VP22; GFP; protein delivery VP22, the product of the UL49 gene of herpes simplex virus 1 is 301 residues in length and is a major structural component of the virus. We previously demonstrated that VP22 traffics between cells by a non-classical Golgi independent mechanism.
2 Transport was observed after introduction of the gene by several routes including transfection or microinjection of the isolated gene in plasmid constructs, or by infection with a non-replicating herpes virus encoding the native VP22 gene. In addition, we showed that this trafficking activity was retained in a fusion protein consisting of VP22 linked to GFP and we suggested that VP22 transport may have potential in the field of gene therapy.
However, in a recent report, Fang and colleagues 3 failed to observe intercellular trafficking of a VP22-GFP fusion protein in transfection experiments and questioned whether the transport property may be a useful adjunct in gene therapy protocols. Here we present the results of additional experiments which confirm and extend our original observations on VP22-GFP trafficking. As in our previous work COS-1 cells were plated in standard culture medium (Dulbecco's modified minimal essential medium containing 10% newborn calf serum) and transfected with expression plasmids for various GFP constructs. In this work, to facilitate examination of live cells, cells were plated in chambered coverslips at 1 x 10 5 cells per chamber. Transfections were performed as previously using the calcium phosphate precipitation technique modified by the use of BES-buffered saline in place of HEPES-buffered saline 4 using 200 ng of plasmid
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Received and accepted 10 November 1998 DNA with no carrier DNA. The test plasmids were as follows; pEGFPN1 (Clontech, Basingstoke, UK) which was the parent plasmid for the VP22 fusions; pGE150 (VP22-GFP), constructed by insertion of the BamHI fragment from pUL49ep into the BamHI site of pEGFPN1 and thus containing the entire VP22 open reading frame from HSV-1 strain 17 linked in frame and N-terminal to the GFP reading frame; 2 pAM4 constructed in a similar way to pGE150 but containing only VP22 residues 1-192 linked in frame to the N-terminus of GFP. Confocal microscopy was performed using a Zeiss LSM410 system attached to an inverted Axiovert 135 microscope (Zeiss, Welwyn, UK). Fields were examined by illumination with the 488 nm laser at 1:30 or 1:100 attenuation using a ×63 oil emersion objective or a ×10 objective for low power magnification.
In the first series of experiments plasmids (200 ng) expressing GFP, GFP-VP22 and GFP-VP22 were transfected into COS-1 cells and the cells processed 40 h after transfection in one of three ways. For detection in live cells, the cells were viewed directly on the coverslips in growth medium. For detection in fixed cells, the same coverslips were rinsed in PBS, fixed in 100% methanol at room temperature for 15 min, rinsed, mounted in Vectashield (Vector Laboratories, Peterborough, UK) and viewed. Finally for antibody detection, coverslips which had been fixed in methanol were stained with anti-GFP antibody (rabbit polyclonal anti-GFP; Clontech) at 1:100 followed by secondary staining using FITC conjugated antirabbit antibody (Vectastain; Vector Laboratories) at 1:100.
After transfection with the control GFP plasmid ( Figure  1 1c). The protein was present in a diffuse pattern in positive cells. Methanol fixation somewhat reduced intrinsic fluorescence of the GFP but even with antibody detection no foci of GFP-containing cells could be detected and the protein was found in a minor population of between 5 and 10% of the cells, mainly as single isolated cells (Figure 1, low magnification, bottom panel) . For VP22-GFP (Figure 1 middle row) , in live cells the fusion protein was detected in an altered pattern being present mainly in the cytoplasm frequently exhibiting a filamentous appearance (Figure 1d ). However when examining live cells, the number of cells containing VP22-GFP remained relatively low and the protein was not detected in adjacent cell nuclei. This picture changed dramatically when examining VP22-GFP in fixed cells (Figure 1e ). In this case intrinsic GFP fluorescence was detected in the nuclei of numerous cells surrounding cells which exhibited much more intense and largely cytoplasmic fluorescence. The presence of the VP22-GFP fusion protein in numerous cells was confirmed using antibody detection with anti-GFP antibody. The panel illustrated for anti-GFP antibody (Figure 1f) shows the fusion protein in a pair of intensely staining cells (arrow), again with a largely cytoplasmic distribution, surrounded by numerous cells with the fusion in a nuclear pattern. Chromatin association of VP22-GFP can be observed in the nucleus of a recipient cell (Figure 1f arrowhead) adjacent to the intensely staining cells. The critical feature of the results is the comparison with the control parental GFP protein which in contrast to VP22-GFP and by whatever detection method, never exhibited fluorescence in a nuclear specific location and never in the pattern of numerous cells surrounding the less frequent but more intensely staining cells. Thus when examining the transfected cells by low power magnification, in this case by antibody detection, GFP was observed in a typical diffuse pattern in approximately 5-10% of the cells, while VP22-GFP was observed in virtually every cell in the two patterns of lower frequency intense and cytoplasmic localisation, combined with numerous cells exhibiting less intense and nuclear accumulation (Figure 1, bottom panels) .
As a further control for this work we examined a
Figure 2 COS cells were transfected with 200 ng of GFP (a, b) or VP22-GFP (c, d) expression vectors, trypsinised 24 h later and plated in a 1:50 mix with untransfected Vero cells. The monolayers were fixed in methanol after a further 16 h incubation and stained simultaneously with anti-T-antigen and anti-GFP antibody. The two right hand panels show low magnification fields for GFP or VP22-GFP.
fusion protein consisting of the N-terminal two thirds of VP22 (residues 1-192) linked to GFP (Figure 1 h-j) . This protein behaved essentially like the control GFP, being detected in a minority of the cells, in a mainly diffuse pattern. Neither fixation and examination of direct GFP fluorescence nor antibody detection enhanced or altered the localisation in any significant way.
In an additional experiment we tested whether cells transfected and expressing VP22-GFP could transfer the protein to nontransfected cells. To this end COS-1 cells transfected with GFP or VP22-GFP expression plasmids as above, were trypsinised 24 h after transfection, mixed with nontransfected Vero cells at a ratio of 1:50 and plated. After further incubation (16 h) the mixed monolayers were stained both with a monoclonal antibody to T-antigen to identify the COS-1 cells, and the anti-GFP antibody to detect GFP from either the control GFP plasmid or VP22-GFP. The field for GFP shows several COS cells (Figure 2a Altogether these results provide compelling reinforcing evidence for the intercellular transport of VP22 and indicate that the VP22-GFP fusion protein retains this ability. We interpret our results on the comparison of detection methods for VP22-GFP localisation to indicate that the level of protein in the recipient cells is below the level of detection required for detection by intrinsic GFP fluorescence in live cells. Fixation presumably results in a concentration effect on the protein, or potentially removes interfering or quenching components. Not unexpectedly antibody detection was more sensitive than GFP fluorescence and clearly demonstrated the fusion protein in numerous surrounding cells. It is possible that the failure of Fang et al to observe transport of VP22-GFP is a quantitative problem and indeed our failure to detect transport in living cells agrees with their results. While these workers also attempted to detect VP22-GFP using anti-GFP antibody, it is also possible that the yields of protein in the cell type (H1299) and time of analysis (24 h) may be lower than those obtained in our routine assays (COS-1, 40-50 h). Nevertheless, we have observed VP22 transport within 20-30 h of transfection in COS-1 cells and have also observed transport in H1299. Other technical aspects of expression or detection, for example the use of a monoclonal antibody to GFP instead of the polyclonal used in our work, may be involved in their failure to detect the protein in recipient cells.
It is difficult to predict how much of a component is required to elicit a biological effect, but clearly many regulatory proteins or enzymes function at relatively low physiological concentrations. We further confirm our proposal that VP22 intercellular transport has significant potential in gene therapy applications with a report in this issue, demonstrating intercellular transport of the herpes virus enzyme thymidine kinase (tk), the retention of enzymatic activity of the chimera, and its enhancement of gancyclovir-mediated cytotoxicity over that obtained with tk alone.
